31P-NMR and differential scanning calorimetry studies for determining vesicles drug physical state and fraction in alendronate liposomes
dc.contributor.author | Afergan, Eyal | |
dc.contributor.author | Najajreh, Yousef | |
dc.contributor.author | Gutman, Dikla | |
dc.contributor.author | Epstein, Hila | |
dc.contributor.author | Elmalak, Omar | |
dc.contributor.author | Golomb, Gershon | |
dc.date.accessioned | 2018-09-05T11:32:17Z | |
dc.date.available | 2018-09-05T11:32:17Z | |
dc.date.issued | 2010-10-15 | |
dc.description.abstract | Background: A liposomal delivery system requires a complete understanding of the physicochemical characteristics of the drug– liposome system in order to predict their behavior and stability in-vitro and in-vivo. Objectives: Develop a rapid and simple experimental method to determine the fractions of the drug, alendronate (ALN), encapsulated and as a free form distributed in the liposomal suspension, and the physical state of the encapsulated drug. Methods: 31P-NMR measurements utilizing Ga+3 as a shifting reagent in comparison to HPLC determinations, theoretical calculations and differential scanning calorimetry (DSC) studies of various liposomal ALN formulations. Results: The 31P-NMR demonstrated that titrating liposomal ALN with increasing amounts of Ga+3 induced a signifi cant shift in the exterior fraction without changing the interior fraction. Quantitative determination of the encapsulated and non-encapsulated fractions of ALN has been achieved at Ga+3 concentrations of 3.2-25mM. The DSC study revealed that none of the formulation ingredients is in a solid phase. Conclusions: 31P-NMR was found to be sensitive enough to allow accurate differentiation of the distributed fractions of ALN, encapsulated and the non-encapsulated free form. Based on theoretical calculations and DSC analysis it can be concluded that ALN is dissolved in the aqueous core of the liposome. | en_US |
dc.description.sponsorship | This work was supported in part by a grant from Biorest Ltd., Israel (GG). GG is affi liated with the David R. Bloom Center for Pharmacy at The Hebrew University of Jerusalem. | en_US |
dc.identifier.citation | Afergan E, Najajreh Y, Gutman D, Epstein H, Elmalak O, et al. (2010) 31P-NMR and Differential Scanning Calorimetry Studies for Determining Vesicle’s Drug Physical State and Fraction in Alendronate Liposomes. J Bioanal Biomed 2: 125-131. doi:10.4172/1948-593X.1000035 | en_US |
dc.identifier.issn | 1948-593X | |
dc.identifier.uri | https://dspace.alquds.edu/handle/20.500.12213/847 | |
dc.language.iso | en_US | en_US |
dc.publisher | OMICS Publishing Group | en_US |
dc.subject | 31P-NMR | en_US |
dc.subject | Liposomes | en_US |
dc.subject | Encapsulation | en_US |
dc.subject | Differential scanning calorimetry (DSC) | en_US |
dc.subject | Alendronate | en_US |
dc.subject | Gallium nitrate | en_US |
dc.title | 31P-NMR and differential scanning calorimetry studies for determining vesicles drug physical state and fraction in alendronate liposomes | en_US |
dc.type | Article | en_US |